A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase

Background: A combination nonavalent pneumococcal-group C meningococcal conjugate vaccine (Pnc9-MenC) was previously found to be safe and immunogenic when administered to infants at 2, 3 and 4 monts. This study describes the persistence of immunity at 12 months of age and the immunologic response to...

Full description

Bibliographic Details
Main Authors: Riddell, A, Buttery, J, McVernon, J, Chantler, T, Lane, L, Bowen-Morris, J, Diggle, L, Morris, R, Lockhart, S, Pollard, A, Cartwright, K, Moxon, E
Other Authors: International Society for Vaccines
Format: Journal article
Language:English
Published: Elsevier 2007
Subjects: